Is science killing sport?: Gene therapy and its possible abuse in doping

EMBO Reports

Volumn 8, Issue 5, 2007, Pages 433-435

  Filipp, Fabian ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH HORMONE; STEROID;

ARTICLE; ATHLETE; DOPING; DRUG MISUSE; GENE MUTATION; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; IMMUNE DEFICIENCY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MOLECULAR BIOLOGY; MUSCLE MASS; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; SPORT; TRANSGENIC MOUSE;

ANIMALS; COMPETITIVE BEHAVIOR; DOPING IN SPORTS; GENE THERAPY; HUMANS; SPORTS;

EID: 34247853494     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.1038/sj.embor.7400968     Document Type: Article

References (6)

1. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci USA 95: 15603-15607
2. Haisma HJ, de Hon O (2006) Gene doping. Int J Sports Med 27: 257-266
3. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387 83-90
4. Schneider AJ, Friedmann T (2006) Gene doping in sports: The science and ethics of genetically modified athletes. Adv Genet 51: 1-110
5. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688
6. WADA (2007) The 2007 Prohibited List. Montreal, Canada: World Anti-Doping Agency. www.wada-ama.org